Baptist Health Miami Neuroscience Institute has one of the most robust neuroscience research programs in the region. Many of our trials and research studies lead to better treatments and outcomes for patients.
Current Clinical Trials
Our multifaceted research program focuses on several areas, including:
We focus not only on new treatment approaches, but also improvements to hospital processes. Ultimately, we aim to create better patient outcomes while advancing the field of neuroscience.
Baptist Health Research
The Baptist Health Research program focuses on the acceleration of healthcare discovery and innovation through collaborative clinical research across Baptist Health, which supports the organization’s long-standing commitment to providing the highest quality of patient care guided by evidence-based practices.
Clinical Research Supervisor
Clinical Research Coordinator
Clinical Research Coordinator
Baptist Health Spine Symposium
The Baptist Health Spine Symposium presents state-of-the-art, evidence-based spine care, incorporating clinical trial data from the previous 18 months. Symposium attendees participate in short, goal-directed lectures from experts across multiple subspecialties, with the opportunity for direct feedback. We encourage all interested healthcare professionals who treat patients with common spinal disorders to join us for a full morning of interactive lectures and lively panel discussions.
Miami Neuroscience Symposium
This symposium offers a broad curriculum focusing on state-of-the-art, evidence-based practices for clinicians and healthcare professionals who treat and care for neuroscience patients from the emergency department through rehabilitation. The expert faculty will engage participants through complex cases, novel treatment strategies and lively panel discussions. The goal of the program is to share the most innovative and evidence-based clinical practices that have been implemented and are available to optimize patient outcomes throughout all areas of neuroscience.
Miami Brain Symposium
The Miami Brain Symposium focuses on state-of-the-art approaches in the management of primary and metastatic central nervous systems tumors, along with an understanding of current standards of care and a look at future directions. This symposium engages participants as the expert faculty navigate through complex cases, novel treatment strategies and lively panel discussions.
The Baptist Health Miami Neuroscience Institute along with the Baptist Foundation, hosts an annual invited lectureship series covering a variety of topics in clinical neurosciences as well as technology and innovation. These lectures are available to the neuroscience community at large, as well as to members of the community of Miami Dade County and the State of Florida through in-person and Zoom presentations.
- Charles G. Drake Cerebrovascular Lectureship
- Dade Lunsford Stereotactic Radiosurgery Lectureship
- Marie Curie Women in Neuroscience Lectureship
- Steven Kirshblum Physical Medicine & Rehabilitation Lectureship
Baptist Health Miami Neuroscience Institute and FIU's Herbert Wertheim College of Medicine
Baptist Health Miami Neuroscience Institute and Florida International University’s Herbert Wertheim College of Medicine are collaborating to offer a new clinical trial for patients with Alzheimer’s disease. The study uses low-intensity focused ultrasound to disrupt brain changes that lead to the neuron damage that causes memory and cognition problems in patients.
Is Earlier Better? Clinical Trial Explores Early Radiation Therapy as Protective Treatment Against High-Risk Spine Metastases
A research team at Baptist Health recently began enrollment in a randomized-controlled clinical trial exploring early radiation therapy as a prophylactic treatment for patients with asymptomatic or minimally symptomatic high-risk metastatic disease to the spine.
Miami Neuroscience Institute is involved with four projects funded through the National Institutes of Health (NIH), including two clinical trials.
We are also participating in two NIH studies that look at why stroke patients are more likely to suffer another stroke. The goal of these studies is to track risk factors, so we can better educate patients and reduce the risk of another stroke.
Participating in these national trials requires a high standard in the quality of our research and our facilities, which translates to better outcomes and care for our patients.
Patients who participate in our clinical trials must match certain criteria. If your doctor or nurse believes you would be a good candidate for one of our trials or studies, they will notify you before you are discharged from the hospital, and a clinical research coordinator will contact you with more details.
If you want to learn more about clinical trial opportunities at Miami Neuroscience Institute, talk with your doctor or view a list of current clinical trials.
One of our nurse-led research programs has reduced the time it takes to treat stroke patients by half. Most patients who arrive in one of our Emergency Centers with ischemic stroke now receive clot-busting tissue plasminogen activator (tPA) treatment in just over 21 minutes. A similar program is now working to reduce the time it takes to get stroke patients to our interventional neuroradiologists to remove the blood clot causing the stroke through a minimally invasive endovascular approach.
Miami Neuroscience Institute is also piloting a program that uses video conferencing in ambulances to jumpstart some of the tests and treatments we now do when the patient arrives at the hospital.
A doctor or research nurse from the research team will provide you with important facts about the clinical trial. You will learn about its purpose, tests and procedures as well as possible risks and benefits.
Clinical trials are conducted in accordance with strict scientific and ethical principles. Groups of experts at the national and local levels, including the Institutional Review Board (IRB) of the research organization implementing the trial, approve research studies before they begin. An IRB, which is comprised of doctors, researchers, community leaders and other consumers, protects your safety by ensuring the study is conducted fairly and you are well-informed of your rights during the study. If you choose to participate in the study, you will be asked to sign a consent form that explains the study. However, even if you sign the consent form, you may stop participating in the study at any time.
- You may have access to promising new therapies that doctors hope will be more effective or less toxic than the standard treatment. In many cases, these therapies are not yet available to patients outside the study.
- You can play an active role in your care by expanding your treatment options.
- You will receive expert medical care during the trial and throughout your treatment.
- Your overall health is closely monitored throughout the trial.
- Participants in randomized studies will not choose the approach they receive.
- Therapies under study are not always better than the standard care.
- New treatments may have unknown side effects or risks.
- What is the purpose of this study?
- How will it help me or other patients?
- What side effects might I experience?
- What other treatment options are available?
- Are there possible long-term risks?
- How will participating in this study affect my daily life?
- What are the treatments, medical tests or procedures I will undergo during the study?
- Who will oversee my care?
- How long will the study last?
- Will my health insurance cover treatments and tests I receive as part of this study?
- What kind of follow-up care will I receive after the study?
Baptist Health Miami Neuroscience Institute's research team is expanding.